Recent advances in the synthesis of anticancer pyrazole derivatives using microwave, ultrasound, and mechanochemical techniques
RSC Advances · 2025 · 15 (9) · 7018-7038
DOI: 10.1039/d4ra08866b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2025. Verfasst von Diana Becerra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia Avenida Central del Norte 39-115 Tunja Colombia diana.becerra08@uptc.e…. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Universidad Pedagógica y Tecnológica de Colombia.
Abstract (Originalsprache)
Pyrazole and its derivatives have attracted considerable attention in pharmaceutical and medicinal chemistry, as reflected in their presence in numerous FDA-approved drugs and clinical candidates.
Autor:innen und Institutionen
- Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia Avenida Central del Norte 39-115 Tunja Colombia diana.becerra08@uptc.edu.co juan.castillo06@uptc.edu.co.
ORCID-Profile: Juan-Carlos Castillo
Förderung
- Universidad Pedagógica y Tecnológica de Colombia
Zitieren
APA
Becerra, D., & Castillo, J. C. (2025). Recent advances in the synthesis of anticancer pyrazole derivatives using microwave, ultrasound, and mechanochemical techniques. RSC Advances, 15(9), 7018-7038. https://doi.org/10.1039/d4ra08866b
Vancouver
Becerra D, Castillo JC. Recent advances in the synthesis of anticancer pyrazole derivatives using microwave, ultrasound, and mechanochemical techniques. RSC Advances. 2025;15(9):7018-7038. doi:10.1039/d4ra08866b
BibTeX
@article{Becerra2025,
author = {Becerra, Diana and Castillo, Juan-Carlos},
title = {Recent advances in the synthesis of anticancer pyrazole derivatives using microwave, ultrasound, and mechanochemical techniques},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {9},
pages = {7018--7038},
doi = {10.1039/d4ra08866b}
}
EUVIMED